ANIK - Anika Therapeutics, Inc.
IEX Last Trade
16.24
0.050 0.308%
Share volume: 357
Last Updated: Fri 27 Dec 2024 08:28:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$16.19
0.05
0.31%
Summary score
8%
Profitability
0%
Dept financing
5%
Liquidity
70%
Performance
1%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-3.34%
Return on assets
-1.51%
Return on sales
-14%
Return on invested capital
-7.9%
Total debt ratio
21.15%
Debt ratio change over timeo
-0.96%
Current Ratio
5.71%
Quick Ratio
4.32%
Cash Position Ratio
3.02%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.82%
Return on assets
-1.49%
Return on sales
-10.72%
Return on invested capital
-23.72%
Total debt ratio
19.19%
Debt ratio change over timeo
-5.26%
Current Ratio
5.73%
Quick Ratio
4.08%
Cash Position Ratio
2.51%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-2.16%
Return on assets
-1.92%
Return on sales
-12.49%
Return on invested capital
-5.91%
Total debt ratio
20.93%
Debt ratio change over time
-1.25%
Current Ratio
5.59%
Quick Ratio
3.85%
Cash Position Ratio
2.41%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-28.57%
Return on assets
-84.53%
Return on sales
36.1%
Return on invested capital
60.74%
Total debt ratio
-96.2%
Debt ratio change over time
-0.96%
Current Ratio
-13.09%
Quick Ratio
-7.92%
Cash Position Ratio
-4.17%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ANIK | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -3.34% | 13.79% | 34.47% | 7.43% |
| Return on assets | -1.51% | 2.76% | 3.15% | 5.62% |
| Return on sales | -14% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -7.9% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 21.15% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.96% | 308.97% | -6.99% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 5.73% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.08% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.51% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 11% | 25% | 58% |
| Short-term ratios | ANIK | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.82% | 13.77% | 13.25% | 3.8% |
| Return on assets | -1.49% | 2.43% | 1.89% | 3.09% |
| Return on sales | -10.72% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -23.72% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 19.19% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -5.26% | 46.38% | -72.08% | 1.51% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 5.73% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.08% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.51% | 0.36% | 1.28% | 2.93% |
| Liquididy | 68% | 11% | 30% | 74% |